BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17039231)

  • 21. Pathogenesis of follicular lymphoma.
    Kridel R; Sehn LH; Gascoyne RD
    J Clin Invest; 2012 Oct; 122(10):3424-31. PubMed ID: 23023713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphoma.
    Arcinas M; Heckman CA; Mehew JW; Boxer LM
    Cancer Res; 2001 Jul; 61(13):5202-6. PubMed ID: 11431360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical significance of detecting strong bcl-2 protein expression with flow cytometry in follicular lymphoma].
    Kobayashi S; Motomura S; Kishi Y; Hashimoto C; Maruta A; Kodama F
    Rinsho Ketsueki; 2004 Jul; 45(7):530-8. PubMed ID: 15359912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Follicular center cell lymphoma with the t(14;18) translocation in which the rearranged BCL-2 gene is silent.
    Wang J; Raffeld M; Medeiros LJ; Longo DL; Jaffe ES; Duffey P; Stetler-Stevenson M
    Leukemia; 1993 Nov; 7(11):1834-9. PubMed ID: 7694006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of BCL-2/IgH hybrid gene RNA expression during treatment of T(14;18)-bearing follicular lymphomas.
    Soubeyran P; Hostein I; Debled M; Eghbali H; Soubeyran I; Bonichon F; Astier-Gin T; Hoerni B
    Br J Cancer; 1999 Nov; 81(5):860-9. PubMed ID: 10555759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Premalignant cell dynamics in indolent B-cell malignancies.
    Milpied P; Nadel B; Roulland S
    Curr Opin Hematol; 2015 Jul; 22(4):388-96. PubMed ID: 26049761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follicular lymphoma frequently originates in the salivary gland.
    Nakamura S; Ichimura K; Sato Y; Nakamura S; Nakamine H; Inagaki H; Sadahira Y; Ohshima K; Sakugawa S; Kondo E; Yanai H; Ohara N; Yoshino T
    Pathol Int; 2006 Oct; 56(10):576-83. PubMed ID: 16984613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases.
    Mollejo M; Rodríguez-Pinilla MS; Montes-Moreno S; Algara P; Dogan A; Cigudosa JC; Juarez R; Flores T; Forteza J; Arribas A; Piris MA
    Am J Surg Pathol; 2009 May; 33(5):730-8. PubMed ID: 19194277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.
    Limpens J; de Jong D; van Krieken JH; Price CG; Young BD; van Ommen GJ; Kluin PM
    Oncogene; 1991 Dec; 6(12):2271-6. PubMed ID: 1766674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bcl-2 gene rearrangements in primary B-cell lymphoma of the gastrointestinal tract reveal follicular lymphoma as a subtype.
    Straka C; Mielke B; Eichelmann A; Trede I; Ho AD; Möller P
    Leukemia; 1993 Feb; 7(2):268-73. PubMed ID: 8426481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of follicular lymphoma in situ in consecutively analysed reactive lymph nodes.
    Henopp T; Quintanilla-Martínez L; Fend F; Adam P
    Histopathology; 2011 Jul; 59(1):139-42. PubMed ID: 21771030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unbalanced expression of bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival.
    Ghia P; Boussiotis VA; Schultze JL; Cardoso AA; Dorfman DM; Gribben JG; Freedman AS; Nadler LM
    Blood; 1998 Jan; 91(1):244-51. PubMed ID: 9414291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs.
    Devan J; Janikova A; Mraz M
    Semin Oncol; 2018 Oct; 45(5-6):291-302. PubMed ID: 30360879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The bcl-2 oncogene and apoptosis.
    Hockenbery DM
    Semin Immunol; 1992 Dec; 4(6):413-20. PubMed ID: 1286168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells.
    Heckman CA; Wheeler MA; Boxer LM
    Oncogene; 2003 Sep; 22(39):7891-9. PubMed ID: 12970736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas.
    Weiss LM; Warnke RA; Sklar J; Cleary ML
    N Engl J Med; 1987 Nov; 317(19):1185-9. PubMed ID: 3657890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is t(14;18)(q32;q21) a constant finding in follicular lymphoma? An interphase FISH study on 63 patients.
    Godon A; Moreau A; Talmant P; Baranger-Papot L; Geneviève F; Milpied N; Zandecki M; Avet-Loiseau H
    Leukemia; 2003 Jan; 17(1):255-9. PubMed ID: 12529690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion of C-MYC in the spectrum of transformed follicular lymphoma grade 3b.
    Tzankov A; Höllrigl A; Verdorfer I; Oxle H
    Hum Pathol; 2007 Jan; 38(1):191-2; author reply 192-3. PubMed ID: 17169631
    [No Abstract]   [Full Text] [Related]  

  • 39. Significantly different bcl-2 expression profiles in gastric and non-gastric primary extranodal high-grade B-cell lymphomas.
    Cogliatti SB; Griesser H; Peng H; Du MQ; Isaacson PG; Zimmermann DR; Maibach RC; Schmid U
    J Pathol; 2000 Dec; 192(4):470-8. PubMed ID: 11113864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of chromosomal alteration of 3q27 on nodal B-cell lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 329 consecutive patients.
    Niitsu N; Okamoto M; Nakamura N; Nakamine H; Aoki S; Hirano M; Miura I
    Leuk Res; 2007 Sep; 31(9):1191-7. PubMed ID: 17197022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.